An investigation into the role of P-glycoprotein in Alzheimer's disease lesion pathogenesis

Neuroscience Letters

Volumn 487, Issue 3, 2011, Pages 389-393

  Jeynes, Brian ^a   Provias, John ^b  

^a BROCK UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

AD lesions; Alzheimer's disease; Blood brain barrier; Capillaries; P glycoprotein

Indexed keywords

CARRIER PROTEIN; GLYCOPROTEIN P;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CAPILLARY DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; SENILE PLAQUE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD-BRAIN BARRIER; CAPILLARIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LDL-RECEPTOR RELATED PROTEIN 1; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; P-GLYCOPROTEIN; PLAQUE, AMYLOID; RECEPTORS, IMMUNOLOGIC;

EID: 78650524176     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.10.063     Document Type: Article

References (28)

1. Bartels A.L., Kortekaas R., Bart J., Willemsen A.T., de Klerk O.L., de Vries J.J., van Oostrom J.C., Leenders K.L. Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol. Aging 2009, 30:1818-1824.
2. Bendayan R., Lee G., Bendayan M. Functional expression and localization of p-glycoprotein at the blood brain barrier. Microsc. Res. Tech. 2002, 57:365-380.
3. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. (Berl.) 1991, 82:239-259.
4. Cirrito J.R., Deane R., Fagan A.M., Jiang H., Prior J.L., Sagare A., Bales K.R., Paul S.M., Zlokovic B.V., Piwnica-Worms D., Holtzman D.M. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model. J. Clin. Invest. 2005, 115:3285-3290.
5. Deane R., Wu Z., Sagare A., Davis J., Du Yan S., Hamm K., Xu F., Parisi M., LaRue B., Hu H.W., Spijkers P., Guo H., Song X., Lenting P.J., Van Nostrand W.E., Zlokovic B.V. LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms. Neuron 2004, 43:333-344.
6. Donahue J.E., Flaherty S.L., Johanson C.E., Duncan J.A., Silverberg G.D., Miller M.C., Tavares R., Yang W., Wu Q., Sabo E., Hovanesian V., Stopa E.G. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol. 2006, 112:405-415.
7. Gregory G.C., Halliday G.H. What is the dominant Abeta species in human brain tissue? A review. Neurotox. Res. 2005, 7:29-41.
8. Hartz A.M.S., Miller D.S., Bauer B. Restoring blood-brain barrier P-glycoprotein reduces brain Aβ in a mouse model of Alzheimer's disease. Mol. Pharmacol. 2010, 77:715-723.
9. Hawkins B.T., Sykes D.B., Miller D.S. Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by Vascular Endothelial Growth Factor. J. Neurosci. 2010, 30:1417-1425.
10. Irie K., Murakami K., Masuda Y., Morimoto A., Ohigashi H., Ohashi R., Takegoshi K., Nagao M., Shimizu T., Shirasawa T. Structure of β-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease. J. Biosci. Bioeng. 2005, 99:437-447.
11. Ito S., Ohtsuki S., Terasaki T. Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier. Neurosci. Res. 2006, 56:246-252.
12. Jeynes B., Provias J. Evidence for altered LRP/RAGE in Alzheimer lesion pathogenesis. Curr. Alzheimer Res. 2008, 5:432-437.
13. Jeynes B., Provias J. Correlations between capillary expressed NOS isoforms presence and AD lesions in Alzheimer and normative brains. Neurosci. Lett. 2009, 463:244-248.
14. Katsuno T., Morishima-Kawashima M., Saito Y., Yamanouchi H., Ishiura S., Murayama S., Ihara Y. Independent accumulations of tau and amyloid beta-protein in the human entorhinal cortex. Neurology 2005, 64:687-692.
15. Lam F.C., Liu R., Lu P., Shapiro A.B., Renoir J.M., Sharom F.M., Reiner P.B. β-Amyloid efflux mediated by p-glycoprotein. J. Neurochem. 2001, 76:1121-1128.
16. Mann D.M., Iwatsubo T., Pickering-Brown S.M., Owen F., Saido T.C., Perry R.H. Preferential deposition of amyloid β protein (Aβ) in the form Aβ40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele. Neurosci. Lett. 1997, 22:81-84.
17. Miller D.S., Bauer B., Hartz A.M.S. Modulation of p-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol. Rev. 2008, 60:196-209.
18. Nazer B., Hong S., Selkoe D.J. LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-β peptide in a blood-brain barrier in vitro model. Neurobiol. Dis. 2008, 30:94-102.
19. Pekcec A., Schneider E.L., Baumgärtner W., Stein V.M., Tipold A., Potschka H. Age-dependent decline of blood-brain barrier P-glycoprotein expression in canine brain. Neurobiol. Aging 2009, 15(October). PMID: 19836857.
20. Pimplikar S.W. Reassessing the amyloid cascade hypothesis of Alzheimer's disease. Int. J. Biochem. Cell Biol. 2009, 41:1261-1268.
21. Provias J., Jeynes B. Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase. Curr. Neurovasc. Res. 2008, 5:199-205.
22. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
23. Ueno M. Mechanisms of the penetration of blood-borne substances into the brain. Curr. Neuropharmacol. 2009, 7:142-149.
24. Urquhart B.L., Kim R.B. Blood-brain barrier transporters and response to CNS-active drugs. Eur. J. Clin. Pharmacol. 2009, 65:1063-1070.
25. Vogelgesang S., Warzok R.W., Cascorbi I., Kunert-Keil C., Schroeder E., Kroemer H.K., Siegmund W., Walker L.C., Pahnke J. The role of P-glycoprotein in cerebral amyloid angiopathy: implications for the early pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 2004, 1:121-125.
26. Vogelgesang S. Deposition of Alzheimer's [beta]-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 2002, 12:535-541.
27. Yamauchi A., Dohgu S., Nishioku T., Shuto H., Naito M., Tsuruo T., Sawada Y., Kataoka Y. An inhibitory role of nitric oxide in the dynamic regulation of the blood-brain barrier function. Cell. Mol. Neurobiol. 2007, 27:263-270.
28. Zlokovic B.V., Deane R., Sallstrom J., Chow N., Miano J.M. Neurovascular pathways and Alzheimer amyloid β-peptide. Brain Pathol. 2005, 15:78-83.